ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 612,75
0,56%
Dow Jones
38 834,86
0,15%
DAX
18 169,23
0,56%
Brent Oil
84,565
-0,15%
Bitcoin
65 600,47
0,97%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Revolution Medicines Inc (RVMD)

  7. Revolution Medicines Inc (RVMD) Actualités

RVMD Revolution Medicines Inc

37,72
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:09:41
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Revolution Medicines Inc RVMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 37,72 10:09:41
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
37,72
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/6/202422:05GLOBERevolution Medicines to Participate in Goldman Sachs 45th..
08/5/202422:02GLOBERevolution Medicines Reports First Quarter 2024 Financial..
01/5/202422:05GLOBERevolution Medicines to Report Financial Results for First..
09/4/202421:34GLOBERevolution Medicines Announces Publication on the Discovery..
08/4/202417:36GLOBERevolution Medicines Announces Publications on the Discovery..
04/4/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
28/3/202421:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
05/3/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202423:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26/2/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202422:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
26/2/202422:04EDGAR2Form 8-K - Current report
20/2/202422:05GLOBERevolution Medicines to Report Financial Results for Fourth..
09/2/202423:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
24/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:18EDGAR2Form 144 - Report of proposed sale of securities
09/1/202420:15EDGAR2Form 8-K - Current report
04/1/202413:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
20/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202300:22EDGAR2Form 144 - Report of proposed sale of securities
14/12/202323:48EDGAR2Form 144 - Report of proposed sale of securities
21/11/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:14EDGAR2Form 144 - Report of proposed sale of securities
16/11/202320:58EDGAR2Form CERT - Certification by an exchange approving..
15/11/202322:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
15/11/202302:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202302:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202315:20EDGAR2Form 8-K - Current report
09/11/202315:10GLOBERevolution Medicines Completes Acquisition of EQRx
08/11/202317:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
06/11/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
06/11/202322:05EDGAR2Form 8-K - Current report
01/11/202312:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202312:11EDGAR2Form 425 - Prospectuses and communications, business..
01/11/202312:08EDGAR2Form 8-K - Current report
01/11/202312:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
31/10/202321:15GLOBERevolution Medicines to Report Financial Results for Third..
24/10/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202312:13EDGAR2Form 425 - Prospectuses and communications, business..
23/10/202312:11EDGAR2Form 8-K - Current report
22/10/202308:30GLOBERevolution Medicines Presents Promising Clinical Activity..
13/10/202317:54EDGAR2Form 8-K - Current report
13/10/202317:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
04/10/202322:05GLOBERevolution Medicines to Present New Clinical Data at Major..

Dernières Valeurs Consultées

NASDAQ
RVMD
Revolution Medicines
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés